| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.811 | 0.002 | 0.817 | Cyclic AMP phosphodiesterase inhibitor | 0.807 0.002 DB01412 0.817 0.002 DB00277 0.735 0.003 DBMET00222 0.788 0.002 DBMET00223 0.781 0.002 DBMET00271 0.682 0.003 DBMET00611 0.181 0.11 DBMET00612 0.719 0.003 DBMET00560 | DB00277 | |
| 0.781 | 0.004 | 0.781 | Vasodilator, peripheral | 0.624 0.013 DB01412 0.559 0.02 DB00277 0.506 0.027 DBMET00222 0.621 0.014 DBMET00223 0.299 0.097 DBMET00271 0.425 0.048 DBMET00611 0.348 0.074 DBMET00560 | ||
| 0.756 | 0.004 | 0.756 | Bronchodilator | 0.497 0.005 DB01412 0.715 0.004 DB00277 0.725 0.004 DBMET00222 0.542 0.004 DBMET00223 0.585 0.004 DBMET00271 0.435 0.005 DBMET00611 0.157 0.029 DBMET00612 0.523 0.004 DBMET00560 | ||
| 0.638 | 0.002 | 0.638 | TRPA1 antagonist | 0.322 0.004 DB01412 0.364 0.004 DB00277 0.336 0.004 DBMET00222 0.354 0.004 DBMET00223 0.112 0.015 DBMET00271 0.227 0.005 DBMET00611 0.163 0.008 DBMET00560 | ||
| 0.615 | 0.004 | 0.615 | Diuretic | 0.447 0.01 DB01412 0.572 0.005 DB00277 0.513 0.007 DBMET00222 0.458 0.01 DBMET00223 0.403 0.013 DBMET00271 0.278 0.026 DBMET00611 0.29 0.024 DBMET00560 | ||
| 0.608 | 0.005 | 0.608 | Vasodilator | 0.535 0.009 DB01412 0.451 0.016 DB00277 0.561 0.008 DBMET00222 0.608 0.005 DBMET00223 0.508 0.011 DBMET00271 0.445 0.017 DBMET00611 0.57 0.007 DBMET00560 | ||
| 0.593 | 0.006 | 0.593 | Psychostimulant | 0.432 0.018 DB01412 0.493 0.011 DB00277 0.456 0.015 DBMET00222 0.401 0.022 DBMET00223 0.287 0.046 DBMET00271 0.289 0.046 DBMET00611 0.183 0.09 DBMET00560 | ||
| 0.581 | 0.009 | 0.581 | Vasodilator, coronary | 0.409 0.032 DB01412 0.451 0.023 DB00277 0.368 0.047 DBMET00222 0.442 0.025 DBMET00223 0.333 0.064 DBMET00271 0.322 0.071 DBMET00611 0.342 0.059 DBMET00560 | ||
| 0.585 | 0.019 | 0.619 | Toll-Like receptor 7 agonist | 0.484 0.035 DB01412 0.606 0.017 DB00277 0.566 0.021 DBMET00222 0.556 0.023 DBMET00223 0.619 0.015 DBMET00271 0.356 0.079 DBMET00611 0.607 0.016 DBMET00560 | DBMET00271 | |
| 0.576 | 0.02 | 0.612 | Toll-Like receptor agonist | 0.476 0.037 DB01412 0.599 0.017 DB00277 0.558 0.022 DBMET00222 0.548 0.024 DBMET00223 0.612 0.016 DBMET00271 0.349 0.082 DBMET00611 0.601 0.017 DBMET00560 | DBMET00271 | |
| 0.552 | 0.018 | 0.552 | Spasmolytic | 0.342 0.055 DB01412 0.344 0.054 DB00277 0.443 0.032 DBMET00222 0.374 0.046 DBMET00223 0.212 0.11 DBMET00271 0.263 0.086 DBMET00611 0.28 0.078 DBMET00560 | ||
| 0.54 | 0.018 | 0.546 | Immunomodulator | 0.546 0.017 DB01412 0.216 0.145 DB00277 0.379 0.05 DBMET00222 0.498 0.023 DBMET00223 0.212 0.15 DBMET00271 0.216 0.146 DBMET00611 0.24 0.123 DBMET00612 | DB01412 | |
| 0.523 | 0.013 | 0.523 | Hypoxia-inducible factor 1 alpha inhibitor | 0.323 0.055 DB01412 0.513 0.013 DB00277 0.377 0.036 DBMET00222 0.325 0.054 DBMET00223 0.339 0.049 DBMET00271 0.256 0.095 DBMET00611 | ||
| 0.506 | 0.002 | 0.506 | Electrolyte absorption antagonist | 0.313 0.004 DB01412 0.317 0.004 DB00277 0.274 0.004 DBMET00222 0.318 0.004 DBMET00223 0.167 0.014 DBMET00271 0.222 0.006 DBMET00611 0.158 0.017 DBMET00560 | ||
| 0.506 | 0.003 | 0.583 | Adenosine A1 receptor antagonist | 0.417 0.004 DB01412 0.583 0.003 DB00277 0.5 0.003 DBMET00222 0.503 0.003 DBMET00223 0.547 0.003 DBMET00271 0.403 0.004 DBMET00611 0.353 0.005 DBMET00560 | DB00277 | |
| 0.501 | 0.003 | 0.534 | Adenosine A2 receptor antagonist | 0.369 0.004 DB01412 0.534 0.003 DB00277 0.48 0.003 DBMET00222 0.493 0.003 DBMET00223 0.506 0.003 DBMET00271 0.38 0.004 DBMET00611 0.334 0.005 DBMET00560 | DB00277 | |
| 0.482 | 0.003 | 0.482 | Phosphodiesterase I inhibitor | 0.414 0.003 DB01412 0.467 0.003 DB00277 0.354 0.004 DBMET00222 0.388 0.004 DBMET00223 0.362 0.004 DBMET00271 0.243 0.007 DBMET00611 0.336 0.004 DBMET00560 | ||
| 0.465 | 0.003 | 0.487 | Adenosine A2a receptor antagonist | 0.315 0.005 DB01412 0.487 0.003 DB00277 0.423 0.004 DBMET00222 0.437 0.004 DBMET00223 0.449 0.003 DBMET00271 0.338 0.004 DBMET00611 0.257 0.007 DBMET00560 | DB00277 | |
| 0.446 | 0.005 | 0.571 | Phosphodiesterase inhibitor | 0.336 0.011 DB01412 0.42 0.006 DB00277 0.561 0.005 DBMET00222 0.506 0.005 DBMET00223 0.529 0.005 DBMET00271 0.406 0.007 DBMET00611 0.571 0.005 DBMET00560 | DBMET00560 | |
| 0.476 | 0.036 | 0.476 | Cholesterol antagonist | 0.276 0.107 DB01412 0.293 0.096 DB00277 0.33 0.074 DBMET00222 0.281 0.104 DBMET00223 0.295 0.095 DBMET00611 0.191 0.173 DBMET00560 | ||
| 0.463 | 0.037 | 0.505 | GABA C receptor rho-3 antagonist | 0.477 0.032 DB01412 0.477 0.032 DB00277 0.441 0.045 DBMET00222 0.477 0.032 DBMET00223 0.477 0.032 DBMET00271 0.505 0.024 DBMET00611 0.215 0.189 DBMET00612 0.474 0.033 DBMET00560 | DBMET00611 | |
| 0.426 | 0.003 | 0.497 | Adenosine A2b receptor antagonist | 0.364 0.003 DB01412 0.497 0.002 DB00277 0.496 0.002 DBMET00222 0.469 0.002 DBMET00223 0.496 0.002 DBMET00271 0.388 0.003 DBMET00611 0.062 0.022 DBMET00612 0.385 0.003 DBMET00560 | DB00277 | |
| 0.413 | 0.004 | 0.451 | Phosphodiesterase 5A inhibitor | 0.244 0.005 DB01412 0.399 0.004 DB00277 0.451 0.004 DBMET00222 0.25 0.005 DBMET00223 0.278 0.005 DBMET00271 0.247 0.005 DBMET00611 0.263 0.005 DBMET00560 | DBMET00222 | |
| 0.47 | 0.067 | 0.532 | MAP kinase 1 inhibitor | 0.448 0.079 DB01412 0.337 0.145 DB00277 0.532 0.042 DBMET00222 0.447 0.079 DBMET00223 0.309 0.171 DBMET00271 0.368 0.125 DBMET00611 0.296 0.185 DBMET00560 | DBMET00222 | |
| 0.421 | 0.025 | 0.567 | Cardiotonic | 0.22 0.103 DB01412 0.421 0.025 DB00277 0.567 0.009 DBMET00222 0.436 0.023 DBMET00223 0.465 0.019 DBMET00271 0.328 0.046 DBMET00611 0.47 0.019 DBMET00560 | DBMET00222 | |
| 0.396 | 0.003 | 0.396 | DNA repair enzyme inhibitor | 0.377 0.004 DB01412 0.271 0.005 DB00277 0.291 0.004 DBMET00222 0.365 0.004 DBMET00223 0.235 0.006 DBMET00271 0.234 0.006 DBMET00611 0.206 0.008 DBMET00560 | ||
| 0.401 | 0.008 | 0.401 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.383 0.009 DB01412 0.33 0.016 DB00277 0.284 0.029 DBMET00222 0.347 0.013 DBMET00223 0.292 0.026 DBMET00271 0.298 0.024 DBMET00611 0.23 0.052 DBMET00560 | ||
| 0.396 | 0.004 | 0.433 | Phosphodiesterase V inhibitor | 0.24 0.005 DB01412 0.388 0.004 DB00277 0.433 0.004 DBMET00222 0.253 0.005 DBMET00223 0.282 0.005 DBMET00271 0.241 0.005 DBMET00611 0.26 0.005 DBMET00560 | DBMET00222 | |
| 0.396 | 0.018 | 0.517 | RNA-directed DNA polymerase inhibitor | 0.517 0.01 DB01412 0.399 0.018 DB00277 0.26 0.044 DBMET00222 0.408 0.017 DBMET00223 0.399 0.018 DBMET00271 0.328 0.027 DBMET00611 0.411 0.017 DBMET00560 | DB01412 | |
| 0.344 | 0.003 | 0.344 | Phosphodiesterase 1B inhibitor | 0.266 0.004 DB01412 0.322 0.003 DB00277 0.252 0.004 DBMET00222 0.196 0.005 DBMET00223 0.183 0.005 DBMET00271 0.134 0.008 DBMET00611 0.246 0.004 DBMET00560 | ||
| 0.339 | 0.012 | 0.386 | Tumour necrosis factor antagonist | 0.386 0.007 DB01412 0.251 0.03 DB00277 0.209 0.048 DBMET00222 0.246 0.032 DBMET00223 0.166 0.081 DBMET00271 0.188 0.061 DBMET00611 0.219 0.043 DBMET00560 | DB01412 | |
| 0.412 | 0.09 | 0.433 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.431 0.075 DB01412 0.431 0.075 DB00277 0.38 0.119 DBMET00222 0.431 0.075 DBMET00223 0.431 0.075 DBMET00271 0.433 0.074 DBMET00611 0.407 0.095 DBMET00560 | DBMET00611 | |
| 0.419 | 0.108 | 0.532 | DNA directed DNA polymerase inhibitor | 0.532 0.073 DB01412 0.352 0.137 DB00277 0.445 0.099 DBMET00222 0.368 0.13 DBMET00223 0.297 0.163 DBMET00271 0.3 0.161 DBMET00611 0.283 0.171 DBMET00560 | DB01412 | |
| 0.303 | 0.013 | 0.415 | Adenylate cyclase inhibitor | 0.269 0.017 DB01412 0.415 0.007 DB00277 0.279 0.016 DBMET00222 0.249 0.019 DBMET00223 0.343 0.01 DBMET00271 0.165 0.036 DBMET00611 0.264 0.018 DBMET00560 | DB00277 | |
| 0.292 | 0.004 | 0.303 | Phosphodiesterase 4C inhibitor | 0.163 0.006 DB01412 0.303 0.004 DB00277 0.199 0.005 DBMET00222 0.131 0.009 DBMET00223 0.174 0.005 DBMET00271 0.055 0.039 DBMET00611 0.074 0.024 DBMET00560 | DB00277 | |
| 0.292 | 0.015 | 0.316 | Histone acetyltransferase inhibitor | 0.233 0.034 DB01412 0.227 0.039 DB00277 0.316 0.011 DBMET00222 0.224 0.04 DBMET00223 0.191 0.083 DBMET00271 0.236 0.032 DBMET00611 0.155 0.133 DBMET00560 | DBMET00222 | |
| 0.281 | 0.005 | 0.281 | Phosphodiesterase 4D inhibitor | 0.162 0.016 DB01412 0.264 0.006 DB00277 0.118 0.029 DBMET00222 0.09 0.041 DBMET00223 0.116 0.03 DBMET00271 0.094 0.039 DBMET00560 | ||
| 0.34 | 0.068 | 0.355 | Antithrombotic | 0.264 0.115 DB01412 0.255 0.122 DBMET00222 0.355 0.063 DBMET00223 0.205 0.171 DBMET00271 0.239 0.135 DBMET00611 0.255 0.122 DBMET00560 | DBMET00223 | |
| 0.304 | 0.034 | 0.394 | MAP kinase kinase 2 inhibitor | 0.276 0.043 DB01412 0.253 0.052 DB00277 0.234 0.062 DBMET00222 0.394 0.013 DBMET00223 0.326 0.027 DBMET00271 0.257 0.051 DBMET00611 0.222 0.069 DBMET00612 0.255 0.051 DBMET00560 | DBMET00223 | |
| 0.274 | 0.006 | 0.457 | Adenosine A3 receptor antagonist | 0.237 0.008 DB01412 0.457 0.003 DB00277 0.312 0.005 DBMET00222 0.291 0.006 DBMET00223 0.456 0.003 DBMET00271 0.262 0.007 DBMET00611 0.082 0.041 DBMET00612 0.294 0.005 DBMET00560 | DB00277 | |
| 0.259 | 0.003 | 0.259 | Phosphodiesterase 1A inhibitor | 0.217 0.003 DB01412 0.248 0.003 DB00277 0.234 0.003 DBMET00222 0.178 0.004 DBMET00223 0.162 0.004 DBMET00271 0.163 0.004 DBMET00611 0.243 0.003 DBMET00560 | ||
| 0.258 | 0.005 | 0.708 | Phosphodiesterase III inhibitor | 0.211 0.005 DB01412 0.324 0.004 DB00277 0.582 0.003 DBMET00222 0.493 0.003 DBMET00223 0.554 0.003 DBMET00271 0.502 0.003 DBMET00611 0.708 0.002 DBMET00560 | DBMET00560 | |
| 0.264 | 0.014 | 0.264 | Cell wall synthesis inhibitor | 0.259 0.014 DB01412 0.192 0.033 DB00277 0.157 0.059 DBMET00222 0.213 0.025 DBMET00223 0.153 0.063 DBMET00271 0.159 0.057 DBMET00611 0.191 0.034 DBMET00612 0.121 0.097 DBMET00560 | ||
| 0.325 | 0.099 | 0.325 | Calpain 2 inhibitor | 0.242 0.155 DB00277 0.314 0.106 DBMET00222 0.255 0.146 DBMET00611 | ||
| 0.223 | 0.004 | 0.223 | Phosphodiesterase II inhibitor | 0.204 0.004 DB01412 0.106 0.01 DB00277 0.115 0.008 DBMET00222 0.142 0.005 DBMET00223 0.078 0.019 DBMET00271 0.069 0.024 DBMET00611 | ||
| 0.212 | 0.004 | 0.212 | Phosphodiesterase 2A inhibitor | 0.192 0.004 DB01412 0.088 0.011 DB00277 0.106 0.008 DBMET00222 0.133 0.005 DBMET00223 0.063 0.022 DBMET00271 0.062 0.023 DBMET00611 | ||
| 0.236 | 0.029 | 0.236 | Acetylcholine M1 receptor antagonist | 0.177 0.054 DB01412 0.173 0.056 DB00277 0.171 0.058 DBMET00222 0.144 0.08 DBMET00223 0.164 0.063 DBMET00611 0.162 0.064 DBMET00560 | ||
| 0.211 | 0.005 | 0.211 | Heat shock protein 70 antagonist | 0.183 0.01 DB01412 0.187 0.009 DB00277 0.2 0.006 DBMET00222 0.185 0.01 DBMET00223 0.167 0.02 DBMET00271 0.191 0.008 DBMET00611 0.132 0.113 DBMET00612 0.163 0.024 DBMET00560 | ||
| 0.262 | 0.059 | 0.384 | DNA synthesis inhibitor | 0.384 0.024 DB01412 0.29 0.047 DB00277 0.219 0.095 DBMET00222 0.298 0.044 DBMET00223 0.323 0.037 DBMET00271 0.319 0.038 DBMET00611 0.204 0.117 DBMET00612 0.302 0.043 DBMET00560 | DB01412 | |
| 0.23 | 0.032 | 0.23 | Antipruritic | 0.148 0.096 DB01412 0.144 0.101 DB00277 0.187 0.058 DBMET00223 | ||
| 0.201 | 0.004 | 0.234 | Phosphodiesterase VI inhibitor | 0.145 0.007 DB01412 0.234 0.004 DB00277 0.195 0.004 DBMET00222 0.121 0.012 DBMET00223 0.134 0.009 DBMET00271 0.13 0.01 DBMET00611 0.113 0.014 DBMET00560 | DB00277 | |
| 0.199 | 0.004 | 0.199 | Phosphodiesterase 1C inhibitor | 0.141 0.005 DB01412 0.173 0.004 DB00277 0.162 0.004 DBMET00222 0.111 0.008 DBMET00223 0.097 0.011 DBMET00271 0.108 0.008 DBMET00611 0.163 0.004 DBMET00560 | ||
| 0.192 | 0.005 | 0.236 | Phosphodiesterase 6D inhibitor | 0.163 0.007 DB01412 0.198 0.005 DB00277 0.236 0.004 DBMET00222 0.139 0.013 DBMET00223 0.138 0.013 DBMET00271 0.165 0.007 DBMET00611 0.159 0.008 DBMET00560 | DBMET00222 | |
| 0.199 | 0.013 | 0.199 | Mucolytic | 0.139 0.039 DB01412 0.136 0.041 DB00277 0.15 0.032 DBMET00222 0.123 0.052 DBMET00223 0.128 0.047 DBMET00611 0.102 0.075 DBMET00560 | ||
| 0.196 | 0.011 | 0.31 | Phosphodiesterase 7B inhibitor | 0.169 0.016 DB01412 0.279 0.005 DB00277 0.111 0.045 DBMET00222 0.151 0.021 DBMET00223 0.247 0.006 DBMET00271 0.119 0.038 DBMET00611 0.31 0.004 DBMET00560 | DBMET00560 | |
| 0.192 | 0.015 | 0.341 | Interleukin 8 antagonist | 0.341 0.004 DB01412 0.128 0.052 DB00277 0.134 0.046 DBMET00222 0.159 0.028 DBMET00223 0.125 0.055 DBMET00611 | DB01412 | |
| 0.185 | 0.008 | 0.185 | Phosphodiesterase 4A inhibitor | 0.084 0.019 DB01412 0.183 0.008 DB00277 0.07 0.024 DBMET00222 0.061 0.029 DBMET00223 0.085 0.019 DBMET00271 | ||
| 0.182 | 0.012 | 0.271 | NADH dehydrogenase inhibitor | 0.271 0.007 DB01412 0.213 0.009 DB00277 0.106 0.038 DBMET00222 0.176 0.013 DBMET00223 0.216 0.009 DBMET00271 0.127 0.025 DBMET00611 0.116 0.031 DBMET00560 | DB01412 | |
| 0.181 | 0.013 | 0.181 | Death-associated protein kinase 1 inhibitor | 0.181 0.013 DB01412 0.149 0.04 DBMET00223 | ||
| 0.301 | 0.134 | 0.43 | Beta lactamase inhibitor | 0.235 0.164 DB01412 0.43 0.091 DBMET00222 0.193 0.19 DBMET00223 0.352 0.115 DBMET00611 0.202 0.184 DBMET00560 | DBMET00222 | |
| 0.233 | 0.066 | 0.405 | EphB2 antagonist | 0.373 0.02 DB01412 0.382 0.019 DB00277 0.264 0.05 DBMET00223 0.405 0.016 DBMET00271 | DBMET00271 | |
| 0.249 | 0.083 | 0.602 | Aldehyde oxidase inhibitor | 0.481 0.035 DB01412 0.509 0.032 DB00277 0.207 0.101 DBMET00222 0.338 0.057 DBMET00223 0.602 0.019 DBMET00271 0.319 0.061 DBMET00611 0.525 0.029 DBMET00560 | DBMET00271 | |
| 0.183 | 0.024 | 0.183 | Expectorant | 0.118 0.052 DB01412 0.105 0.063 DB00277 0.129 0.045 DBMET00222 0.104 0.065 DBMET00223 0.107 0.061 DBMET00611 0.091 0.08 DBMET00560 | ||
| 0.169 | 0.01 | 0.169 | Phosphodiesterase 4B inhibitor | 0.102 0.024 DB01412 0.154 0.012 DB00277 0.088 0.031 DBMET00222 0.069 0.044 DBMET00223 0.07 0.044 DBMET00271 | ||
| 0.17 | 0.012 | 0.193 | Phosphodiesterase 3A inhibitor | 0.119 0.022 DB01412 0.193 0.009 DB00277 0.162 0.014 DBMET00222 0.107 0.027 DBMET00223 0.156 0.015 DBMET00271 0.117 0.023 DBMET00560 | DB00277 | |
| 0.19 | 0.037 | 0.209 | Interleukin 1 antagonist | 0.209 0.029 DB01412 0.114 0.098 DBMET00223 | DB01412 | |
| 0.28 | 0.128 | 0.28 | Immunosuppressant | 0.279 0.129 DB01412 0.209 0.187 DBMET00222 0.234 0.163 DBMET00223 | ||
| 0.28 | 0.135 | 0.515 | Histamine release inhibitor | 0.287 0.131 DB01412 0.335 0.107 DB00277 0.345 0.102 DBMET00222 0.367 0.092 DBMET00223 0.413 0.069 DBMET00271 0.435 0.057 DBMET00611 0.515 0.024 DBMET00560 | DBMET00560 | |
| 0.148 | 0.004 | 0.148 | Dipeptidyl peptidase IV inhibitor | 0.077 0.008 DB01412 0.077 0.008 DB00277 0.105 0.005 DBMET00222 0.069 0.01 DBMET00223 0.043 0.034 DBMET00271 0.074 0.009 DBMET00611 0.042 0.036 DBMET00560 | ||
| 0.142 | 0.005 | 0.142 | Dipeptidyl peptidase inhibitor | 0.081 0.013 DB01412 0.084 0.012 DB00277 0.113 0.007 DBMET00222 0.074 0.016 DBMET00223 0.083 0.013 DBMET00611 | ||
| 0.153 | 0.015 | 0.176 | Protein kinase B gamma inhibitor | 0.169 0.012 DB00277 0.066 0.063 DBMET00222 0.154 0.015 DBMET00223 0.176 0.01 DBMET00271 0.101 0.032 DBMET00611 0.149 0.016 DBMET00560 | DBMET00271 | |
| 0.192 | 0.061 | 0.241 | Lipocortins synthesis antagonist | 0.193 0.061 DB00277 0.241 0.037 DBMET00222 0.14 0.121 DBMET00223 0.14 0.121 DBMET00271 0.214 0.048 DBMET00611 0.197 0.058 DBMET00560 | DBMET00222 | |
| 0.173 | 0.043 | 0.183 | CF transmembrane conductance regulator agonist | 0.135 0.106 DB01412 0.183 0.034 DB00277 0.155 0.067 DBMET00223 0.159 0.061 DBMET00271 | DB00277 | |
| 0.134 | 0.005 | 0.235 | Nicotinic acid receptor 1 agonist | 0.106 0.007 DB01412 0.233 0.004 DB00277 0.126 0.005 DBMET00222 0.083 0.01 DBMET00223 0.182 0.004 DBMET00271 0.08 0.011 DBMET00611 0.235 0.004 DBMET00560 | DBMET00560 | |
| 0.162 | 0.036 | 0.224 | Cystathionine beta-synthase inhibitor | 0.13 0.051 DB00277 0.176 0.031 DBMET00222 0.13 0.051 DBMET00223 0.13 0.051 DBMET00271 0.224 0.019 DBMET00611 0.199 0.025 DBMET00560 | DBMET00611 | |
| 0.128 | 0.002 | 0.383 | Phosphodiesterase 6B inhibitor | 0.062 0.005 DB01412 0.164 0.002 DB00277 0.383 0.001 DBMET00222 0.086 0.004 DBMET00223 0.12 0.003 DBMET00271 0.107 0.003 DBMET00611 0.031 0.021 DBMET00612 0.128 0.002 DBMET00560 | DBMET00222 | |
| 0.149 | 0.024 | 0.149 | Transcription factor STAT6 inhibitor | 0.119 0.063 DB01412 0.11 0.081 DB00277 | ||
| 0.131 | 0.008 | 0.176 | Bromodomain-containing protein 4 inhibitor | 0.115 0.01 DB01412 0.09 0.015 DB00277 0.148 0.006 DBMET00222 0.127 0.009 DBMET00223 0.095 0.014 DBMET00271 0.176 0.005 DBMET00611 0.118 0.01 DBMET00560 | DBMET00611 | |
| 0.155 | 0.035 | 0.155 | Sphingosine 1-phosphate receptor 2 antagonist | 0.153 0.038 DB00277 0.142 0.052 DBMET00222 0.133 0.067 DBMET00611 0.121 0.093 DBMET00560 | ||
| 0.127 | 0.012 | 0.201 | Biliverdin reductase inhibitor | 0.201 0.005 DB01412 0.123 0.013 DB00277 0.068 0.033 DBMET00222 0.095 0.02 DBMET00223 0.095 0.02 DBMET00271 0.092 0.021 DBMET00611 0.079 0.026 DBMET00560 | DB01412 | |
| 0.156 | 0.042 | 0.156 | Antibacterial (Helicobacter pylori) | 0.126 0.073 DB01412 0.126 0.073 DB00277 0.135 0.062 DBMET00223 | ||
| 0.16 | 0.046 | 0.237 | MAP kinase kinase inhibitor | 0.232 0.019 DB01412 0.127 0.067 DB00277 0.237 0.018 DBMET00223 0.19 0.032 DBMET00271 0.109 0.086 DBMET00611 0.102 0.092 DBMET00560 | DBMET00223 | |
| 0.274 | 0.162 | 0.31 | MAP kinase kinase 6 inhibitor | 0.31 0.126 DB01412 0.256 0.182 DB00277 0.285 0.15 DBMET00223 0.232 0.215 DBMET00271 | DB01412 | |
| 0.178 | 0.067 | 0.185 | MAP kinase kinase 5 inhibitor | 0.185 0.053 DB01412 0.185 0.053 DBMET00223 | DBMET00223 | |
| 0.115 | 0.005 | 0.172 | Thymidine kinase inhibitor | 0.172 0.003 DB01412 0.141 0.004 DB00277 0.084 0.008 DBMET00222 0.127 0.004 DBMET00223 0.139 0.004 DBMET00271 0.073 0.01 DBMET00611 0.079 0.009 DBMET00560 | DB01412 | |
| 0.112 | 0.004 | 0.112 | Potassium channel small-conductance Ca-activated activator | 0.097 0.004 DB01412 0.067 0.007 DB00277 0.071 0.006 DBMET00223 0.033 0.02 DBMET00271 | ||
| 0.122 | 0.014 | 0.131 | I kappa B kinase 1 inhibitor | 0.131 0.012 DB01412 0.108 0.019 DBMET00223 | DB01412 | |
| 0.146 | 0.039 | 0.279 | Ferrochelatase inhibitor | 0.16 0.034 DB01412 0.16 0.034 DB00277 0.217 0.019 DBMET00222 0.16 0.034 DBMET00223 0.16 0.034 DBMET00271 0.279 0.01 DBMET00611 0.115 0.057 DBMET00612 0.248 0.013 DBMET00560 | DBMET00611 | |
| 0.161 | 0.055 | 0.189 | MAO inhibitor | 0.121 0.074 DB00277 0.189 0.044 DBMET00222 0.12 0.074 DBMET00611 | DBMET00222 | |
| 0.172 | 0.068 | 0.187 | ATPase inhibitor | 0.185 0.051 DB01412 0.184 0.053 DBMET00222 0.151 0.099 DBMET00223 0.187 0.05 DBMET00611 0.168 0.074 DBMET00560 | DBMET00611 | |
| 0.106 | 0.003 | 0.361 | Phosphodiesterase 6C inhibitor | 0.067 0.005 DB01412 0.125 0.002 DB00277 0.361 0.001 DBMET00222 0.076 0.004 DBMET00223 0.091 0.003 DBMET00271 0.093 0.003 DBMET00611 0.049 0.024 DBMET00612 0.111 0.003 DBMET00560 | DBMET00222 | |
| 0.134 | 0.033 | 0.134 | Adenylate kinase inhibitor | 0.125 0.039 DB01412 0.125 0.039 DB00277 0.096 0.074 DBMET00222 0.125 0.039 DBMET00223 0.125 0.039 DBMET00271 0.114 0.049 DBMET00611 0.105 0.06 DBMET00560 | ||
| 0.102 | 0.002 | 0.102 | Adenosine uptake inhibitor | 0.057 0.004 DB01412 0.06 0.004 DB00277 0.061 0.004 DBMET00222 0.05 0.005 DBMET00223 0.039 0.013 DBMET00271 0.052 0.004 DBMET00611 0.04 0.011 DBMET00612 0.035 0.022 DBMET00560 | ||
| 0.103 | 0.003 | 0.377 | Phosphodiesterase 6A inhibitor | 0.031 0.006 DB01412 0.156 0.002 DB00277 0.377 0.002 DBMET00222 0.042 0.004 DBMET00223 0.092 0.003 DBMET00271 0.076 0.003 DBMET00611 0.127 0.002 DBMET00560 | DBMET00222 | |
| 0.105 | 0.005 | 0.109 | Adenosine deaminase inhibitor | 0.109 0.004 DB01412 0.095 0.006 DB00277 0.071 0.013 DBMET00222 0.097 0.006 DBMET00223 0.086 0.008 DBMET00271 0.059 0.021 DBMET00611 0.051 0.03 DBMET00560 | DB01412 | |
| 0.108 | 0.009 | 0.209 | Phosphodiesterase VII inhibitor | 0.096 0.015 DB01412 0.109 0.009 DB00277 0.113 0.008 DBMET00222 0.095 0.015 DBMET00223 0.099 0.013 DBMET00271 0.09 0.018 DBMET00611 0.209 0.004 DBMET00560 | DBMET00560 | |
| 0.13 | 0.031 | 0.13 | Anabolic | 0.097 0.066 DB01412 0.097 0.067 DBMET00222 0.091 0.077 DBMET00611 | ||
| 0.135 | 0.036 | 0.135 | Mediator release inhibitor | 0.087 0.085 DB01412 0.111 0.058 DBMET00222 0.087 0.085 DBMET00611 | ||
| 0.128 | 0.03 | 0.149 | Phosphodiesterase IV inhibitor | 0.087 0.055 DB01412 0.133 0.028 DB00277 0.137 0.026 DBMET00222 0.128 0.03 DBMET00223 0.149 0.023 DBMET00271 0.134 0.027 DBMET00560 | DBMET00271 | |
| 0.198 | 0.101 | 0.283 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | 0.283 0.069 DB01412 0.265 0.074 DBMET00222 0.242 0.081 DBMET00611 0.164 0.126 DBMET00560 | DB01412 | |
| 0.279 | 0.182 | 0.279 | Cyclophilin D inhibitor | |||
| 0.113 | 0.017 | 0.124 | Carbamoyl phosphate synthetase inhibitor | 0.124 0.015 DB01412 0.121 0.015 DB00277 0.073 0.033 DBMET00222 0.101 0.02 DBMET00223 0.121 0.015 DBMET00271 0.092 0.023 DBMET00611 0.082 0.028 DBMET00560 | DB01412 | |
| 0.231 | 0.136 | 0.231 | Thyroid hormone antagonist | 0.228 0.138 DBMET00222 | ||
| 0.113 | 0.018 | 0.128 | Caspase 7 inhibitor | 0.091 0.039 DB00277 0.128 0.012 DBMET00222 0.108 0.021 DBMET00611 0.081 0.058 DBMET00560 | DBMET00222 | |
| 0.125 | 0.03 | 0.175 | MAP kinase kinase 1 inhibitor | 0.153 0.015 DB01412 0.12 0.035 DB00277 0.095 0.063 DBMET00222 0.175 0.009 DBMET00223 0.166 0.011 DBMET00271 0.124 0.031 DBMET00611 0.112 0.043 DBMET00560 | DBMET00223 | |
| 0.134 | 0.041 | 0.173 | Xanthine oxidase inhibitor | 0.156 0.032 DB01412 0.123 0.046 DB00277 0.173 0.027 DBMET00223 0.17 0.027 DBMET00271 0.111 0.052 DBMET00611 0.124 0.045 DBMET00560 | DBMET00223 | |
| 0.136 | 0.043 | 0.155 | MAO B inhibitor | 0.098 0.06 DB00277 0.155 0.036 DBMET00222 0.099 0.06 DBMET00611 | DBMET00222 | |
| 0.119 | 0.03 | 0.119 | Interleukin 12 antagonist | 0.094 0.064 DB01412 0.09 0.073 DBMET00223 | ||
| 0.1 | 0.011 | 0.286 | Phosphodiesterase 3B inhibitor | 0.082 0.015 DB01412 0.103 0.01 DB00277 0.286 0.004 DBMET00222 0.187 0.005 DBMET00223 0.191 0.005 DBMET00271 0.169 0.005 DBMET00611 0.149 0.005 DBMET00560 | DBMET00222 | |
| 0.096 | 0.008 | 0.101 | Corticotropin releasing factor 2 receptor antagonist | 0.08 0.017 DB01412 0.093 0.009 DB00277 0.098 0.007 DBMET00222 0.081 0.016 DBMET00223 0.079 0.018 DBMET00271 0.101 0.006 DBMET00611 0.062 0.041 DBMET00560 | DBMET00611 | |
| 0.251 | 0.164 | 0.349 | 15-Lipoxygenase inhibitor | 0.349 0.1 DBMET00222 0.225 0.187 DBMET00223 0.208 0.205 DBMET00611 | DBMET00222 | |
| 0.201 | 0.119 | 0.297 | Immunostimulant | 0.297 0.079 DB01412 | DB01412 | |
| 0.146 | 0.068 | 0.147 | Sphingosine 1-phosphate receptor 5 antagonist | 0.147 0.067 DB00277 0.133 0.093 DBMET00222 0.132 0.095 DBMET00611 | DB00277 | |
| 0.089 | 0.017 | 0.126 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.126 0.01 DB01412 0.082 0.019 DB00277 0.057 0.038 DBMET00222 0.082 0.019 DBMET00223 0.082 0.019 DBMET00271 0.071 0.025 DBMET00611 0.064 0.031 DBMET00560 | DB01412 | |
| 0.09 | 0.018 | 0.09 | GABA receptor antagonist | 0.081 0.021 DB01412 0.058 0.034 DB00277 0.067 0.027 DBMET00223 | ||
| 0.214 | 0.143 | 0.227 | Thyroid hormone beta antagonist | 0.227 0.133 DBMET00222 | DBMET00222 | |
| 0.146 | 0.078 | 0.177 | Cytidine deaminase inhibitor | 0.177 0.059 DB01412 0.147 0.078 DB00277 0.142 0.081 DBMET00223 0.159 0.069 DBMET00271 0.144 0.08 DBMET00611 0.13 0.091 DBMET00560 | DB01412 | |
| 0.106 | 0.039 | 0.148 | Polo-like kinase-1 inhibitor | 0.148 0.017 DB01412 0.089 0.063 DB00277 0.097 0.05 DBMET00222 0.135 0.023 DBMET00223 0.109 0.037 DBMET00271 0.127 0.027 DBMET00611 0.104 0.041 DBMET00560 | DB01412 | |
| 0.145 | 0.08 | 0.191 | GABA C receptor rho-2 antagonist | 0.191 0.034 DB01412 0.161 0.06 DB00277 0.154 0.068 DBMET00222 0.161 0.06 DBMET00223 0.161 0.06 DBMET00271 0.185 0.039 DBMET00611 0.169 0.052 DBMET00560 | DB01412 | |
| 0.066 | 0.002 | 0.331 | Phosphodiesterase 6H inhibitor | 0.034 0.005 DB01412 0.077 0.002 DB00277 0.331 0.001 DBMET00222 0.044 0.004 DBMET00223 0.055 0.003 DBMET00271 0.058 0.003 DBMET00611 0.023 0.017 DBMET00612 0.071 0.002 DBMET00560 | DBMET00222 | |
| 0.066 | 0.002 | 0.331 | Phosphodiesterase 6G inhibitor | 0.034 0.005 DB01412 0.077 0.002 DB00277 0.331 0.001 DBMET00222 0.044 0.004 DBMET00223 0.055 0.003 DBMET00271 0.058 0.003 DBMET00611 0.023 0.017 DBMET00612 0.071 0.002 DBMET00560 | DBMET00222 | |
| 0.11 | 0.051 | 0.145 | UDP-glucose 4-epimerase inhibitor | 0.134 0.035 DB01412 0.108 0.053 DB00277 0.115 0.046 DBMET00222 0.108 0.053 DBMET00223 0.108 0.053 DBMET00271 0.145 0.031 DBMET00611 0.129 0.038 DBMET00560 | DBMET00611 | |
| 0.064 | 0.005 | 0.072 | ATM kinase inhibitor | 0.042 0.015 DB01412 0.037 0.022 DB00277 0.072 0.004 DBMET00222 0.038 0.021 DBMET00223 0.062 0.005 DBMET00611 | DBMET00222 | |
| 0.07 | 0.011 | 0.109 | Phosphodiesterase 7A inhibitor | 0.061 0.021 DB01412 0.055 0.03 DB00277 0.066 0.014 DBMET00222 0.054 0.031 DBMET00223 0.061 0.02 DBMET00611 0.109 0.004 DBMET00560 | DBMET00560 | |
| 0.063 | 0.006 | 0.063 | Purinergic P2X agonist | 0.039 0.013 DB01412 0.043 0.011 DB00277 0.039 0.013 DBMET00222 0.039 0.013 DBMET00223 0.027 0.019 DBMET00271 0.03 0.017 DBMET00611 | ||
| 0.099 | 0.042 | 0.158 | Bromodomain-containing protein 2 inhibitor | 0.135 0.015 DB01412 0.13 0.017 DBMET00222 0.131 0.017 DBMET00223 0.099 0.041 DBMET00271 0.156 0.007 DBMET00611 0.158 0.007 DBMET00560 | DBMET00560 | |
| 0.065 | 0.008 | 0.065 | Guanylate cyclase inhibitor | 0.043 0.029 DB01412 | ||
| 0.096 | 0.043 | 0.096 | Histamine H1 receptor antagonist | 0.078 0.059 DB00277 | ||
| 0.075 | 0.024 | 0.075 | Acyl-CoA dehydrogenase inhibitor | 0.06 0.033 DB01412 0.06 0.033 DB00277 0.06 0.033 DBMET00223 0.06 0.033 DBMET00271 0.053 0.04 DBMET00611 | ||
| 0.083 | 0.033 | 0.083 | MAP kinase 7 inhibitor | 0.083 0.036 DB01412 0.083 0.036 DB00277 | ||
| 0.137 | 0.087 | 0.14 | Ca2+-transporting ATPase inhibitor | 0.129 0.127 DB01412 0.129 0.127 DB00277 0.132 0.11 DBMET00222 0.129 0.127 DBMET00223 0.129 0.127 DBMET00271 0.14 0.072 DBMET00611 0.136 0.09 DBMET00560 | DBMET00611 | |
| 0.054 | 0.005 | 0.054 | CF transmembrane conductance regulator antagonist | 0.038 0.035 DB01412 0.042 0.022 DB00277 0.051 0.008 DBMET00222 0.046 0.013 DBMET00223 0.038 0.033 DBMET00271 0.051 0.008 DBMET00611 0.038 0.036 DBMET00560 | ||
| 0.242 | 0.197 | 0.329 | DNA polymerase beta inhibitor | 0.252 0.191 DB01412 0.329 0.15 DBMET00222 | DBMET00222 | |
| 0.055 | 0.011 | 0.055 | Angiotensin AT1 receptor antagonist | 0.051 0.017 DB00277 | ||
| 0.053 | 0.008 | 0.087 | Hypoxanthine phosphoribosyltransferase inhibitor | 0.077 0.005 DB01412 0.078 0.004 DB00277 0.029 0.018 DBMET00222 0.068 0.006 DBMET00223 0.087 0.004 DBMET00271 0.048 0.01 DBMET00611 0.061 0.007 DBMET00560 | DBMET00271 | |
| 0.048 | 0.004 | 0.137 | DNA polymerase III inhibitor | 0.084 0.002 DB01412 0.041 0.005 DB00277 0.052 0.004 DBMET00222 0.062 0.003 DBMET00223 0.054 0.003 DBMET00271 0.06 0.003 DBMET00611 0.137 0.002 DBMET00612 0.053 0.003 DBMET00560 | DBMET00612 | |
| 0.155 | 0.113 | 0.216 | DNA methylase inhibitor | 0.216 0.069 DB01412 0.178 0.094 DBMET00223 | DB01412 | |
| 0.113 | 0.074 | 0.113 | Acetylcholine muscarinic antagonist | |||
| 0.075 | 0.036 | 0.087 | 5 Hydroxytryptamine 3A antagonist | 0.072 0.039 DB01412 0.087 0.025 DB00277 0.082 0.029 DBMET00222 0.079 0.032 DBMET00223 0.086 0.025 DBMET00271 0.086 0.026 DBMET00611 0.082 0.029 DBMET00560 | DB00277 | |
| 0.102 | 0.064 | 0.151 | GABA C receptor agonist | 0.117 0.051 DB01412 0.151 0.033 DB00277 0.103 0.063 DBMET00222 0.117 0.051 DBMET00223 0.151 0.033 DBMET00271 0.134 0.041 DBMET00611 0.118 0.051 DBMET00560 | DBMET00271 | |
| 0.098 | 0.061 | 0.108 | Interleukin 1 beta converting enzyme inhibitor | 0.108 0.048 DBMET00222 0.088 0.075 DBMET00611 | DBMET00222 | |
| 0.072 | 0.038 | 0.085 | Glutamate (mGluR7) antagonist | 0.07 0.043 DBMET00222 0.085 0.022 DBMET00611 0.077 0.031 DBMET00560 | DBMET00611 | |
| 0.058 | 0.025 | 0.061 | Antiviral (Hepatitis D) | 0.061 0.02 DB01412 0.047 0.044 DB00277 0.059 0.023 DBMET00223 0.048 0.041 DBMET00271 0.05 0.036 DBMET00560 | DB01412 | |
| 0.155 | 0.123 | 0.163 | Anticonvulsant | 0.163 0.114 DB01412 0.141 0.14 DB00277 0.149 0.13 DBMET00560 | DB01412 | |
| 0.037 | 0.007 | 0.088 | Thymidine phosphorylase inhibitor | 0.057 0.004 DB01412 0.043 0.006 DB00277 0.052 0.005 DBMET00222 0.068 0.004 DBMET00223 0.064 0.004 DBMET00271 0.058 0.004 DBMET00611 0.088 0.003 DBMET00560 | DBMET00560 | |
| 0.077 | 0.048 | 0.086 | Glutamate dehydrogenase inhibitor | 0.086 0.039 DB01412 0.084 0.041 DB00277 0.071 0.055 DBMET00223 0.084 0.041 DBMET00271 0.071 0.055 DBMET00611 | DB01412 | |
| 0.119 | 0.091 | 0.297 | Ribosomal protein S6 kinase inhibitor | 0.297 0.012 DB01412 0.19 0.041 DB00277 0.136 0.075 DBMET00223 0.193 0.04 DBMET00271 | DB01412 | |
| 0.041 | 0.013 | 0.041 | Angiotensin II receptor antagonist | 0.037 0.019 DB00277 | ||
| 0.043 | 0.014 | 0.043 | Purinergic P2X3 antagonist | |||
| 0.168 | 0.141 | 0.21 | 5 Hydroxytryptamine 3E antagonist | 0.173 0.126 DB01412 0.21 0.048 DB00277 0.173 0.126 DBMET00223 0.21 0.048 DBMET00271 0.177 0.113 DBMET00611 0.169 0.141 DBMET00560 | DBMET00271 | |
| 0.073 | 0.045 | 0.094 | Phosphofructokinase-1 inhibitor | 0.094 0.034 DB01412 0.059 0.057 DBMET00611 | DB01412 | |
| 0.045 | 0.017 | 0.088 | Nicotinic acid receptor agonist | 0.053 0.013 DB01412 0.072 0.008 DB00277 0.052 0.014 DBMET00222 0.033 0.03 DBMET00223 0.041 0.02 DBMET00271 0.042 0.019 DBMET00611 0.088 0.005 DBMET00560 | DBMET00560 | |
| 0.031 | 0.008 | 0.039 | Acid ceramidase inhibitor | 0.039 0.004 DB01412 0.028 0.012 DB00277 0.037 0.005 DBMET00222 0.033 0.006 DBMET00223 0.028 0.012 DBMET00271 0.037 0.005 DBMET00611 0.034 0.006 DBMET00560 | DB01412 | |
| 0.043 | 0.021 | 0.051 | Glucagon-like peptide 1 receptor antagonist | 0.049 0.014 DB00277 0.051 0.013 DBMET00222 0.038 0.033 DBMET00611 | DBMET00222 | |
| 0.052 | 0.03 | 0.118 | Antimetabolite | 0.084 0.019 DB01412 0.091 0.018 DB00277 0.056 0.028 DBMET00222 0.074 0.021 DBMET00223 0.118 0.014 DBMET00271 0.053 0.029 DBMET00611 0.059 0.026 DBMET00560 | DBMET00271 | |
| 0.06 | 0.039 | 0.074 | Heat shock protein 90 beta antagonist | 0.074 0.025 DB00277 0.058 0.044 DBMET00271 | DB00277 | |
| 0.164 | 0.145 | 0.181 | ErbB-1 antagonist | 0.181 0.114 DB01412 0.181 0.114 DB00277 0.181 0.114 DBMET00223 0.181 0.114 DBMET00271 | DBMET00271 | |
| 0.03 | 0.011 | 0.055 | Thymidine kinase (Herpes simplex virus 1) inhibitor | 0.055 0.003 DB01412 0.037 0.006 DB00277 0.025 0.023 DBMET00222 0.037 0.006 DBMET00223 0.043 0.004 DBMET00271 0.029 0.013 DBMET00611 0.027 0.017 DBMET00560 | DB01412 | |
| 0.035 | 0.018 | 0.035 | ATR kinase inhibitor | 0.032 0.025 DB01412 0.035 0.018 DBMET00223 | ||
| 0.024 | 0.008 | 0.04 | Thymidine kinase (Herpes simplex virus 2) inhibitor | 0.04 0.003 DB01412 0.032 0.004 DB00277 0.027 0.005 DBMET00223 0.032 0.004 DBMET00271 0.02 0.018 DBMET00611 | DB01412 | |
| 0.069 | 0.053 | 0.094 | Benzodiazepine agonist | 0.069 0.052 DB00277 0.072 0.048 DBMET00222 0.085 0.035 DBMET00223 0.085 0.035 DBMET00271 0.094 0.029 DBMET00611 0.085 0.035 DBMET00560 | DBMET00611 | |
| 0.016 | 0.002 | 0.023 | DNA polymerase III subunit alpha inhibitor | 0.023 0.002 DB01412 0.008 0.004 DB00277 0.013 0.003 DBMET00223 0.007 0.005 DBMET00271 0.007 0.005 DBMET00611 | DB01412 | |
| 0.021 | 0.007 | 0.021 | Adenosine A2 receptor agonist | 0.018 0.009 DB00277 0.015 0.012 DBMET00223 | ||
| 0.055 | 0.041 | 0.098 | Argininosuccinate synthase inhibitor | 0.098 0.02 DB01412 0.073 0.029 DB00277 0.056 0.04 DBMET00223 0.073 0.029 DBMET00271 0.054 0.042 DBMET00611 | DB01412 | |
| 0.08 | 0.068 | 0.08 | mTOR complex 2 inhibitor | 0.078 0.075 DB00277 0.078 0.075 DBMET00223 0.079 0.072 DBMET00271 | ||
| 0.079 | 0.066 | 0.09 | Bcr-Abl kinase inhibitor | 0.086 0.056 DB01412 0.09 0.052 DBMET00223 0.074 0.072 DBMET00271 | DBMET00223 | |
| 0.074 | 0.062 | 0.095 | Interferon agonist | 0.095 0.033 DB01412 0.077 0.058 DBMET00223 0.072 0.067 DBMET00611 0.08 0.052 DBMET00560 | DB01412 | |
| 0.099 | 0.088 | 0.323 | DNA polymerase I inhibitor | 0.184 0.034 DB01412 0.323 0.01 DB00277 0.294 0.012 DBMET00271 0.171 0.039 DBMET00612 0.102 0.084 DBMET00560 | DB00277 | |
| 0.029 | 0.018 | 0.029 | Purinergic P2Y15 antagonist | 0.027 0.022 DB01412 0.027 0.022 DB00277 0.027 0.022 DBMET00223 0.027 0.022 DBMET00271 | ||
| 0.016 | 0.005 | 0.064 | DNA polymerase III polC-type inhibitor | 0.034 0.002 DB01412 0.014 0.006 DB00277 0.019 0.004 DBMET00222 0.023 0.003 DBMET00223 0.021 0.004 DBMET00271 0.022 0.003 DBMET00611 0.064 0.002 DBMET00612 0.021 0.004 DBMET00560 | DBMET00612 | |
| 0.19 | 0.179 | 0.19 | Transcription factor NF kappa B inhibitor | |||
| 0.179 | 0.169 | 0.179 | Transcription factor STAT inhibitor | |||
| 0.065 | 0.056 | 0.16 | Alpha 1b adrenoreceptor antagonist | 0.086 0.042 DB00277 0.129 0.027 DBMET00222 0.106 0.033 DBMET00223 0.129 0.027 DBMET00271 0.125 0.028 DBMET00611 0.16 0.02 DBMET00560 | DBMET00560 | |
| 0.126 | 0.117 | 0.179 | MAP kinase 3 inhibitor | 0.137 0.091 DB01412 0.157 0.058 DB00277 0.146 0.073 DBMET00223 0.179 0.035 DBMET00271 | DBMET00271 | |
| 0.013 | 0.004 | 0.013 | Corticotropin releasing factor antagonist | 0.009 0.007 DBMET00611 | ||
| 0.078 | 0.07 | 0.079 | Transforming growth factor beta 3 antagonist | 0.079 0.068 DB00277 | DB00277 | |
| 0.06 | 0.054 | 0.076 | Interferon inducer | 0.076 0.028 DB01412 0.062 0.049 DBMET00223 0.06 0.053 DBMET00611 0.066 0.041 DBMET00560 | DB01412 | |
| 0.02 | 0.015 | 0.02 | Geranylgeranyltransferase I inhibitor | |||
| 0.074 | 0.07 | 0.074 | ErbB-3 antagonist | 0.073 0.072 DB01412 | ||
| 0.046 | 0.044 | 0.067 | Ornithine carbamoyltransferase inhibitor | 0.067 0.027 DB01412 | DB01412 | |
| 0.131 | 0.129 | 0.156 | DNA methyltransferase I inhibitor | 0.156 0.098 DB01412 0.134 0.124 DBMET00223 | DB01412 | |
| 0.047 | 0.047 | 0.091 | Acetylcholine muscarinic agonist | 0.063 0.032 DBMET00222 0.063 0.032 DBMET00223 0.053 0.04 DBMET00271 0.091 0.019 DBMET00611 0.079 0.023 DBMET00560 | DBMET00611 | |
| 0.069 | 0.07 | 0.174 | Proto-oncogene tyrosine-protein kinase c-hck inhibitor | 0.079 0.053 DB01412 0.09 0.042 DB00277 0.157 0.012 DBMET00223 0.174 0.008 DBMET00271 0.075 0.059 DBMET00560 | DBMET00271 | |
| 0.029 | 0.03 | 0.037 | Fumarate hydratase inhibitor | 0.037 0.021 DB01412 | DB01412 | |
| 0.057 | 0.059 | 0.087 | Acetylcholine M5 receptor agonist | 0.075 0.038 DBMET00611 0.087 0.028 DBMET00560 | DBMET00560 | |
| 0.089 | 0.091 | 0.189 | 5 Hydroxytryptamine 3A agonist | 0.091 0.087 DB01412 0.091 0.087 DB00277 0.13 0.048 DBMET00222 0.091 0.087 DBMET00223 0.091 0.087 DBMET00271 0.172 0.025 DBMET00611 0.189 0.018 DBMET00560 | DBMET00560 | |
| 0.015 | 0.017 | 0.043 | O6-alkylguanine-DNA alkyltransferase inhibitor | 0.016 0.013 DB01412 0.034 0.003 DB00277 0.022 0.005 DBMET00223 0.043 0.002 DBMET00271 0.019 0.008 DBMET00560 | DBMET00271 | |
| 0.012 | 0.014 | 0.017 | Egl nine homolog 1 inhibitor | 0.017 0.008 DB01412 0.016 0.009 DBMET00223 | DB01412 | |
| 0.009 | 0.014 | 0.017 | Purine nucleoside phosphorylase inhibitor | 0.014 0.005 DB01412 0.014 0.005 DB00277 0.012 0.007 DBMET00223 0.017 0.004 DBMET00271 | DBMET00271 | |
| 0.009 | 0.014 | 0.016 | Egl nine homolog 3 inhibitor | 0.014 0.006 DB00277 0.016 0.005 DBMET00271 | DBMET00271 | |
| 0.045 | 0.049 | 0.049 | GABA A receptor antagonist | 0.049 0.043 DB00277 | DB00277 | |
| 0.077 | 0.084 | 0.111 | MAO A inhibitor | 0.111 0.057 DBMET00222 | DBMET00222 | |
| 0.038 | 0.047 | 0.05 | Histamine H1 receptor agonist | 0.043 0.033 DB01412 0.05 0.018 DB00277 0.043 0.033 DBMET00223 0.05 0.018 DBMET00271 | DBMET00271 | |
| 0.007 | 0.016 | 0.01 | CXC chemokine 3 receptor agonist | 0.01 0.006 DBMET00223 | DBMET00223 | |
| 0.07 | 0.08 | 0.085 | Histamine N-methyltransferase inhibitor | 0.079 0.068 DB01412 0.085 0.061 DB00277 0.079 0.068 DBMET00223 0.085 0.061 DBMET00271 | DBMET00271 | |
| 0.008 | 0.02 | 0.013 | Egl nine homolog 2 inhibitor | 0.013 0.008 DBMET00271 | DBMET00271 | |
| 0.095 | 0.109 | 0.166 | Alpha-N-acetylglucosaminidase inhibitor | 0.128 0.07 DBMET00222 0.166 0.047 DBMET00611 0.137 0.063 DBMET00612 0.146 0.058 DBMET00560 | DBMET00611 | |
| 0.07 | 0.083 | 0.078 | MAP kinase kinase 7 inhibitor | 0.075 0.061 DB01412 0.078 0.053 DB00277 0.075 0.061 DBMET00223 0.078 0.053 DBMET00271 | DBMET00271 | |
| 0.053 | 0.067 | 0.101 | Alpha adrenoreceptor agonist | 0.059 0.057 DB01412 0.08 0.038 DB00277 0.088 0.033 DBMET00223 0.101 0.028 DBMET00271 | DBMET00271 | |
| 0.039 | 0.056 | 0.074 | mTOR inhibitor | 0.064 0.025 DBMET00223 0.074 0.02 DBMET00271 0.047 0.042 DBMET00611 | DBMET00271 | |
| 0.043 | 0.062 | 0.079 | EphB4 antagonist | 0.079 0.024 DB01412 | DB01412 | |
| 0.072 | 0.093 | 0.116 | Antihistaminic | 0.116 0.045 DB00277 | DB00277 | |
| 0.079 | 0.101 | 0.112 | GABA C receptor rho-1 antagonist | 0.112 0.047 DB01412 0.11 0.049 DB00277 0.09 0.077 DBMET00223 0.11 0.049 DBMET00271 0.108 0.052 DBMET00611 0.096 0.068 DBMET00560 | DB01412 | |
| 0.029 | 0.054 | 0.067 | Acetylcholine M1 receptor agonist | 0.038 0.035 DBMET00223 0.067 0.02 DBMET00611 0.052 0.025 DBMET00560 | DBMET00611 | |
| 0.072 | 0.1 | 0.136 | Ephrin antagonist | 0.136 0.041 DB01412 | DB01412 | |
| 0.026 | 0.054 | 0.037 | Transforming growth factor beta 2 antagonist | 0.037 0.016 DB01412 | DB01412 | |
| 0.13 | 0.157 | 0.148 | Cyclin-dependent kinase 3 inhibitor | 0.148 0.101 DB01412 0.143 0.113 DB00277 | DB01412 | |
| 0.039 | 0.068 | 0.064 | 5 Hydroxytryptamine 3 antagonist | 0.064 0.032 DB00277 0.063 0.033 DBMET00271 | DB00277 | |
| 0.003 | 0.033 | 0.007 | DNA topoisomerase III inhibitor | 0.007 0.005 DBMET00560 | DBMET00560 | |
| 0.01 | 0.04 | 0.017 | 4-Hydroxyphenylpyruvate dioxygenase inhibitor | 0.017 0.007 DBMET00222 0.016 0.009 DBMET00611 | DBMET00222 | |
| 0.025 | 0.057 | 0.056 | Alpha 1d adrenoreceptor agonist | 0.056 0.013 DB00277 0.056 0.013 DBMET00271 | DBMET00271 | |
| 0.06 | 0.093 | 0.1 | Histamine antagonist | 0.1 0.048 DB00277 | DB00277 | |
| 0.048 | 0.081 | 0.138 | Alpha 1 adrenoreceptor antagonist | 0.083 0.051 DB00277 0.138 0.032 DBMET00222 0.087 0.049 DBMET00223 0.138 0.032 DBMET00271 0.125 0.035 DBMET00611 0.115 0.038 DBMET00560 | DBMET00271 | |
| 0.048 | 0.082 | 0.085 | 5 Hydroxytryptamine 1 antagonist | 0.085 0.044 DBMET00222 0.073 0.051 DBMET00611 | DBMET00222 | |
| 0.025 | 0.059 | 0.049 | Vascular adhesion protein 1 inhibitor | 0.049 0.016 DB00277 0.04 0.025 DBMET00271 | DB00277 | |
| 0.027 | 0.062 | 0.045 | Tryptophan 5 hydroxylase inhibitor | 0.045 0.008 DB01412 | DB01412 | |
| 0.038 | 0.073 | 0.169 | Cyclin B inhibitor | 0.052 0.042 DB01412 0.169 0.005 DB00277 0.163 0.005 DBMET00271 | DB00277 | |
| 0.165 | 0.201 | 0.209 | Gastrin inhibitor | 0.208 0.137 DB01412 0.187 0.169 DB00277 0.209 0.135 DBMET00611 0.181 0.178 DBMET00560 | DBMET00611 | |
| 0.102 | 0.14 | 0.119 | Mannose-6-phosphate isomerase inhibitor | 0.114 0.111 DBMET00611 0.119 0.103 DBMET00560 | DBMET00560 | |
| 0.045 | 0.083 | 0.151 | HIV-1 reverse transcriptase inhibitor | 0.122 0.021 DB01412 0.06 0.059 DBMET00223 0.08 0.042 DBMET00611 0.079 0.043 DBMET00612 0.151 0.014 DBMET00560 | DBMET00560 | |
| 0.021 | 0.059 | 0.039 | 5 Hydroxytryptamine 3B antagonist | 0.039 0.022 DB00277 0.037 0.024 DBMET00222 0.038 0.023 DBMET00271 0.038 0.022 DBMET00611 0.032 0.03 DBMET00560 | DB00277 | |
| 0.117 | 0.157 | 0.224 | Interleukin antagonist | 0.224 0.072 DB01412 | DB01412 | |
| 0.032 | 0.073 | 0.058 | Phosphatidylinositol 3-kinase delta inhibitor | 0.058 0.039 DBMET00271 | DBMET00271 | |
| 0.013 | 0.056 | 0.02 | Glutaminyl-peptide cyclotransferase inhibitor | 0.02 0.017 DBMET00271 | DBMET00271 | |
| 0.058 | 0.101 | 0.153 | Alpha adrenoreceptor antagonist | 0.097 0.058 DB00277 0.129 0.044 DBMET00222 0.095 0.06 DBMET00223 0.153 0.037 DBMET00271 0.123 0.046 DBMET00611 0.112 0.05 DBMET00560 | DBMET00271 | |
| 0.056 | 0.1 | 0.079 | Phosphodiesterase VIII inhibitor | 0.079 0.035 DB01412 | DB01412 | |
| 0.045 | 0.09 | 0.07 | Cyclin B3 inhibitor | 0.07 0.046 DB01412 | DB01412 | |
| 0.03 | 0.075 | 0.074 | AICAR transformylase inhibitor | 0.044 0.03 DB01412 0.051 0.022 DB00277 0.047 0.027 DBMET00223 0.074 0.009 DBMET00271 0.048 0.025 DBMET00612 0.044 0.03 DBMET00560 | DBMET00271 | |
| 0.038 | 0.084 | 0.092 | 5 Hydroxytryptamine 1A antagonist | 0.092 0.035 DBMET00222 0.076 0.043 DBMET00611 | DBMET00222 | |
| 0.036 | 0.082 | 0.066 | Lysine-specific demethylase 1A inhibitor | 0.066 0.021 DB01412 | DB01412 | |
| 0.026 | 0.074 | 0.052 | AMPA receptor antagonist | 0.052 0.03 DB01412 0.046 0.035 DBMET00223 | DB01412 | |
| 0.039 | 0.087 | 0.188 | Cyclin B1 inhibitor | 0.056 0.049 DB01412 0.185 0.005 DB00277 0.188 0.005 DBMET00271 | DBMET00271 | |
| 0.165 | 0.213 | 0.25 | Tyrosine 3 hydroxylase inhibitor | 0.217 0.108 DBMET00222 0.25 0.068 DBMET00611 0.233 0.086 DBMET00560 | DBMET00611 | |
| 0.112 | 0.161 | 0.195 | Anesthetic general | 0.152 0.112 DBMET00223 0.139 0.126 DBMET00271 0.181 0.086 DBMET00611 0.195 0.077 DBMET00560 | DBMET00560 | |
| 0.043 | 0.094 | 0.063 | 5 Hydroxytryptamine 3 agonist | 0.059 0.049 DBMET00611 0.063 0.044 DBMET00560 | DBMET00560 | |
| 0.039 | 0.092 | 0.075 | Cyclin D1 inhibitor | 0.075 0.023 DBMET00612 | DBMET00612 | |
| 0.037 | 0.091 | 0.07 | Cyclin A2 inhibitor | 0.07 0.038 DB00277 0.067 0.041 DBMET00271 | DB00277 | |
| 0.032 | 0.086 | 0.167 | Cyclin B2 inhibitor | 0.051 0.046 DB01412 0.164 0.005 DB00277 0.167 0.005 DBMET00271 | DBMET00271 | |
| 0.026 | 0.08 | 0.044 | Stearoyl-CoA desaturase inhibitor | 0.044 0.03 DBMET00271 | DBMET00271 | |
| 0.037 | 0.092 | 0.061 | Cyclin H inhibitor | 0.061 0.038 DB00277 | DB00277 | |
| 0.079 | 0.134 | 0.104 | Epidermal growth factor receptor kinase inhibitor | 0.104 0.092 DBMET00271 | DBMET00271 | |
| 0.031 | 0.087 | 0.051 | Glutamate (mGluR group III) antagonist | 0.046 0.027 DB01412 0.045 0.028 DB00277 0.051 0.02 DBMET00271 0.047 0.025 DBMET00560 | DBMET00271 | |
| 0.023 | 0.08 | 0.058 | Protein kinase (CK2) beta inhibitor | 0.034 0.022 DB01412 0.031 0.028 DB00277 0.036 0.018 DBMET00222 0.035 0.02 DBMET00271 0.048 0.008 DBMET00611 0.058 0.005 DBMET00560 | DBMET00560 | |
| 0.105 | 0.164 | 0.126 | Adenylate cyclase stimulant | 0.126 0.11 DBMET00611 | DBMET00611 | |
| 0.178 | 0.239 | 0.267 | Ca2+/calmodulin-dependent kinase IV inhibitor | 0.207 0.147 DB01412 0.267 0.047 DBMET00223 0.248 0.068 DBMET00271 | DBMET00223 | |
| 0.031 | 0.094 | 0.064 | Histamine agonist | 0.064 0.024 DB00277 0.064 0.024 DBMET00271 | DBMET00271 | |
| 0.026 | 0.09 | 0.05 | Bromodomain-containing protein 3 inhibitor | 0.046 0.04 DB01412 0.05 0.034 DBMET00611 0.048 0.036 DBMET00560 | DBMET00611 | |
| 0.064 | 0.13 | 0.181 | DNA directed RNA polymerase inhibitor | 0.181 0.016 DB01412 0.11 0.046 DBMET00223 0.115 0.041 DBMET00271 0.102 0.054 DBMET00611 0.171 0.019 DBMET00560 | DB01412 | |
| 0.032 | 0.101 | 0.061 | Cyclin A inhibitor | 0.061 0.043 DB00277 0.057 0.046 DBMET00271 | DB00277 | |
| 0.029 | 0.099 | 0.058 | Glutamate (mGluR4) antagonist | 0.049 0.022 DB01412 0.048 0.022 DB00277 0.058 0.015 DBMET00271 0.046 0.026 DBMET00560 | DBMET00271 | |
| 0.046 | 0.116 | 0.081 | Phospholipase D inhibitor | 0.074 0.045 DBMET00611 0.081 0.033 DBMET00560 | DBMET00560 | |
| 0.03 | 0.1 | 0.078 | Alpha 1 adrenoreceptor agonist | 0.058 0.039 DB00277 0.078 0.024 DBMET00271 0.052 0.048 DBMET00560 | DBMET00271 | |
| 0.01 | 0.081 | 0.031 | Acetylcholine M4 receptor agonist | 0.031 0.02 DBMET00611 0.028 0.023 DBMET00560 | DBMET00611 | |
| 0.097 | 0.167 | 0.144 | Cyclin-dependent kinase 8 inhibitor | 0.121 0.117 DB01412 0.144 0.085 DBMET00223 0.127 0.108 DBMET00271 0.126 0.108 DBMET00560 | DBMET00223 | |
| 0.023 | 0.095 | 0.043 | Histamine H2 receptor agonist | 0.043 0.029 DB00277 0.043 0.029 DBMET00271 | DBMET00271 | |
| 0.031 | 0.103 | 0.051 | Histamine H4 receptor antagonist | 0.051 0.029 DB00277 0.051 0.029 DBMET00271 | DBMET00271 | |
| 0.023 | 0.095 | 0.093 | Alpha 1d adrenoreceptor antagonist | 0.052 0.047 DB00277 0.054 0.046 DBMET00222 0.083 0.029 DBMET00271 0.058 0.042 DBMET00611 0.093 0.025 DBMET00560 | DBMET00560 | |
| 0.052 | 0.126 | 0.112 | Acetylcholine agonist | 0.077 0.07 DBMET00222 0.104 0.044 DBMET00611 0.112 0.04 DBMET00560 | DBMET00560 | |
| 0.015 | 0.091 | 0.074 | Nicotinic acid receptor 2 agonist | 0.035 0.026 DB00277 0.074 0.009 DBMET00560 | DBMET00560 | |
| 0.068 | 0.149 | 0.1 | GABA C receptor antagonist | 0.098 0.081 DB01412 0.098 0.081 DB00277 0.098 0.081 DBMET00271 0.1 0.078 DBMET00611 | DBMET00611 | |
| 0.008 | 0.093 | 0.106 | Calcitonin gene-related peptide antagonist | 0.025 0.017 DB01412 0.068 0.004 DBMET00222 0.07 0.004 DBMET00223 0.072 0.004 DBMET00271 0.072 0.004 DBMET00611 0.106 0.003 DBMET00560 | DBMET00560 | |
| 0.03 | 0.119 | 0.062 | Purinergic P2 antagonist | 0.062 0.046 DBMET00222 0.059 0.049 DBMET00223 0.059 0.049 DBMET00560 | DBMET00222 | |
| 0.057 | 0.146 | 0.144 | Polo-like kinase-4 inhibitor | 0.093 0.084 DB01412 0.102 0.075 DB00277 0.124 0.053 DBMET00223 0.144 0.04 DBMET00271 | DBMET00271 | |
| 0.051 | 0.143 | 0.111 | Vascular endothelial growth factor 1 antagonist | 0.111 0.059 DBMET00223 | DBMET00223 | |
| 0.129 | 0.221 | 0.248 | 5 Hydroxytryptamine 1E antagonist | 0.197 0.134 DB01412 0.226 0.101 DBMET00222 0.231 0.096 DBMET00611 0.248 0.077 DBMET00560 | DBMET00560 | |
| 0.025 | 0.12 | 0.051 | CC chemokine 4 receptor antagonist | 0.045 0.037 DBMET00223 0.046 0.034 DBMET00611 0.051 0.026 DBMET00560 | DBMET00560 | |
| 0.026 | 0.122 | 0.044 | Kainate receptor agonist | 0.044 0.022 DBMET00611 0.041 0.029 DBMET00560 | DBMET00611 | |
| 0.076 | 0.175 | 0.115 | Activin receptor-like kinase 2 inhibitor | 0.115 0.103 DBMET00271 | DBMET00271 | |
| 0.044 | 0.146 | 0.107 | Myeloperoxidase inhibitor | 0.09 0.049 DB01412 0.107 0.028 DB00277 0.093 0.044 DBMET00271 | DB00277 | |
| 0.055 | 0.16 | 0.095 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.095 0.059 DBMET00611 0.084 0.074 DBMET00560 | DBMET00611 | |
| 0.008 | 0.114 | 0.035 | Uridine phosphorylase inhibitor | 0.029 0.019 DBMET00611 0.035 0.014 DBMET00560 | DBMET00560 | |
| 0.126 | 0.234 | 0.192 | Superoxide dismutase inhibitor | 0.192 0.127 DB01412 0.187 0.132 DBMET00611 | DB01412 | |
| 0.071 | 0.181 | 0.168 | Src kinase inhibitor | 0.121 0.107 DB00277 0.116 0.111 DBMET00223 0.168 0.072 DBMET00271 | DBMET00271 | |
| 0.022 | 0.132 | 0.091 | Alpha 1a adrenoreceptor antagonist | 0.07 0.05 DBMET00222 0.091 0.04 DBMET00271 0.066 0.053 DBMET00611 0.08 0.045 DBMET00560 | DBMET00271 | |
| 0.006 | 0.117 | 0.133 | Calcitonin gene-related peptide 1 receptor antagonist | 0.101 0.004 DBMET00222 0.097 0.004 DBMET00223 0.102 0.004 DBMET00271 0.11 0.004 DBMET00611 0.133 0.003 DBMET00560 | DBMET00560 | |
| 0.059 | 0.173 | 0.16 | Nav1.3 sodium channel blocker | 0.144 0.052 DB00277 0.141 0.054 DBMET00271 0.16 0.042 DBMET00560 | DBMET00560 | |
| 0.138 | 0.253 | 0.197 | Nitric-oxide synthase stimulant | 0.171 0.15 DB01412 0.172 0.148 DB00277 0.171 0.15 DBMET00223 0.197 0.094 DBMET00271 0.174 0.144 DBMET00611 0.186 0.114 DBMET00560 | DBMET00271 | |
| 0.01 | 0.126 | 0.024 | Nicotinic acid receptor 2 antagonist | 0.024 0.023 DBMET00560 | DBMET00560 | |
| 0.112 | 0.23 | 0.162 | Proto-oncogene tyrosine-protein kinase Fyn inhibitor | 0.162 0.116 DBMET00223 | DBMET00223 | |
| 0.05 | 0.168 | 0.065 | MDM2 inhibitor | 0.065 0.054 DBMET00560 | DBMET00560 | |
| 0.051 | 0.172 | 0.172 | c-Src kinase inhibitor | 0.115 0.079 DB00277 0.1 0.09 DBMET00223 0.172 0.045 DBMET00271 | DBMET00271 | |
| 0.154 | 0.277 | 0.228 | 5 Hydroxytryptamine uptake stimulant | 0.193 0.167 DBMET00222 0.228 0.106 DBMET00611 0.209 0.134 DBMET00560 | DBMET00611 | |
| 0.142 | 0.273 | 0.396 | Alpha-glucosidase inhibitor | 0.396 0.117 DBMET00222 | DBMET00222 | |
| 0.058 | 0.189 | 0.139 | Nav1.6 sodium channel blocker | 0.117 0.1 DBMET00222 0.139 0.068 DBMET00560 | DBMET00560 | |
| 0.031 | 0.165 | 0.055 | Dihydroorotate oxidase inhibitor | 0.055 0.039 DBMET00560 | DBMET00560 | |
| 0.036 | 0.172 | 0.137 | Acetylcholine M3 receptor agonist | 0.137 0.026 DBMET00560 | DBMET00560 | |
| 0.085 | 0.222 | 0.153 | Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor | 0.141 0.138 DBMET00223 0.153 0.128 DBMET00271 | DBMET00271 | |
| 0.129 | 0.266 | 0.232 | Peptidyltransferase inhibitor | 0.232 0.065 DB01412 0.179 0.13 DBMET00612 0.201 0.097 DBMET00560 | DB01412 | |
| 0.067 | 0.204 | 0.097 | Acetylcholine release stimulant | 0.097 0.094 DBMET00611 | DBMET00611 | |
| 0.034 | 0.174 | 0.083 | Protein kinase B beta inhibitor | 0.083 0.039 DBMET00271 | DBMET00271 | |
| 0.086 | 0.229 | 0.144 | Dyrk kinase inhibitor | 0.144 0.141 DBMET00271 | DBMET00271 | |
| 0.033 | 0.176 | 0.053 | Pregnane X receptor antagonist | 0.053 0.05 DBMET00560 | DBMET00560 | |
| 0.037 | 0.184 | 0.081 | I kappa B kinase inhibitor | 0.081 0.059 DBMET00223 | DBMET00223 | |
| 0.044 | 0.196 | 0.093 | Prolactin inhibitor | 0.093 0.063 DBMET00611 0.081 0.08 DBMET00560 | DBMET00611 | |
| 0.066 | 0.22 | 0.117 | Histone deacetylase SIRT1 inhibitor | 0.112 0.101 DB00277 0.117 0.095 DBMET00271 | DBMET00271 | |
| 0.052 | 0.207 | 0.153 | Alkylator | 0.1 0.088 DBMET00271 0.125 0.063 DBMET00611 0.153 0.045 DBMET00560 | DBMET00560 | |
| 0.076 | 0.232 | 0.165 | LIM domain kinase 1 inhibitor | 0.142 0.107 DBMET00223 0.165 0.084 DBMET00271 | DBMET00271 | |
| 0.015 | 0.174 | 0.045 | Purinergic P2Y2 antagonist | 0.045 0.013 DB01412 0.04 0.016 DBMET00222 0.034 0.022 DBMET00223 0.034 0.022 DBMET00271 0.044 0.013 DBMET00611 0.041 0.015 DBMET00560 | DB01412 | |
| 0.048 | 0.212 | 0.152 | Proto-oncogene tyrosine-protein kinase Yes inhibitor | 0.152 0.06 DB01412 | DB01412 | |
| 0.077 | 0.251 | 0.205 | Polo-like kinase-3 inhibitor | 0.137 0.101 DBMET00223 0.163 0.071 DBMET00271 0.13 0.109 DBMET00611 0.205 0.042 DBMET00560 | DBMET00560 | |
| 0.046 | 0.226 | 0.134 | Cyclin-dependent kinase inhibitor | 0.102 0.088 DB00277 0.134 0.065 DBMET00271 | DBMET00271 | |
| 0.037 | 0.222 | 0.168 | RET inhibitor | 0.133 0.07 DBMET00223 0.168 0.053 DBMET00271 | DBMET00271 | |
| 0.017 | 0.215 | 0.216 | Raf kinase inhibitor | 0.118 0.026 DBMET00223 0.216 0.011 DBMET00271 0.079 0.045 DBMET00560 | DBMET00271 | |
| 0.103 | 0.304 | 0.194 | MAP-kinase-activated kinase 5 inhibitor | 0.194 0.11 DB01412 0.174 0.142 DB00277 0.174 0.142 DBMET00271 | DB01412 | |
| 0.025 | 0.229 | 0.243 | Protein kinase (Mos, Mil/Raf, MEKK, RIPK, TESK, LIMK, IRAK, ILK, Activin/TGF-beta) inhibitor | 0.144 0.03 DBMET00223 0.243 0.013 DBMET00271 0.087 0.065 DBMET00560 | DBMET00271 | |
| 0.036 | 0.246 | 0.128 | Glycogen synthase kinase-3 alpha inhibitor | 0.103 0.102 DB01412 0.121 0.084 DBMET00223 0.128 0.079 DBMET00271 | DBMET00271 | |
| 0.04 | 0.251 | 0.093 | Alpha 2b adrenoreceptor antagonist | 0.093 0.081 DBMET00271 | DBMET00271 | |
| 0.014 | 0.228 | 0.057 | NMDA receptor glycine site agonist | 0.057 0.049 DBMET00560 | DBMET00560 | |
| 0.011 | 0.227 | 0.173 | Raf kinase B inhibitor | 0.088 0.026 DBMET00223 0.173 0.011 DBMET00271 0.056 0.044 DBMET00560 | DBMET00271 | |
| 0.023 | 0.241 | 0.202 | Cyclin-dependent kinase 1 inhibitor | 0.157 0.038 DB00277 0.202 0.026 DBMET00271 | DBMET00271 | |
| 0.012 | 0.234 | 0.05 | Xanthine dehydrogenase inhibitor | 0.05 0.046 DBMET00271 0.05 0.046 DBMET00560 | DBMET00560 | |
| 0.006 | 0.232 | 0.077 | Histamine H3 receptor agonist | 0.077 0.007 DB00277 0.077 0.007 DBMET00271 | DBMET00271 | |
| 0.028 | 0.255 | 0.075 | Glycine receptor antagonist | 0.075 0.064 DBMET00611 | DBMET00611 | |
| 0.025 | 0.285 | 0.115 | Protein-tyrosine kinase Lyn inhibitor | 0.115 0.089 DBMET00271 | DBMET00271 | |
| 0.02 | 0.282 | 0.072 | CDK1/cyclin B1 inhibitor | 0.072 0.045 DBMET00271 | DBMET00271 | |
| 0.024 | 0.29 | 0.11 | Antiadrenergic | 0.077 0.074 DBMET00222 0.11 0.05 DBMET00271 0.084 0.068 DBMET00611 0.096 0.059 DBMET00560 | DBMET00271 | |
| 0.045 | 0.312 | 0.13 | Alpha 2d adrenoreceptor antagonist | 0.13 0.017 DB00277 0.13 0.017 DBMET00271 | DBMET00271 | |
| 0.022 | 0.3 | 0.107 | Adrenaline antagonist | 0.107 0.05 DBMET00271 0.08 0.069 DBMET00611 0.093 0.058 DBMET00560 | DBMET00271 | |
| 0.089 | 0.378 | 0.17 | 5 Hydroxytryptamine release stimulant | 0.17 0.153 DBMET00611 | DBMET00611 | |
| 0.006 | 0.299 | 0.029 | Alpha 2d adrenoreceptor agonist | 0.029 0.009 DB00277 0.029 0.009 DBMET00271 | DBMET00271 | |
| 0.034 | 0.331 | 0.217 | MAP kinase 12 inhibitor | 0.173 0.031 DBMET00223 0.217 0.018 DBMET00271 0.106 0.089 DBMET00611 0.151 0.041 DBMET00560 | DBMET00271 | |
| 0.042 | 0.34 | 0.11 | mTOR complex 1 inhibitor | 0.11 0.043 DBMET00271 | DBMET00271 | |
| 0.005 | 0.312 | 0.035 | Purinergic P2Y12 antagonist | 0.021 0.018 DBMET00223 0.02 0.019 DBMET00271 0.035 0.01 DBMET00560 | DBMET00560 | |
| 0.021 | 0.341 | 0.094 | Cyclin-dependent kinase 2 inhibitor | 0.094 0.076 DBMET00271 | DBMET00271 | |
| 0.125 | 0.476 | 0.261 | Caspase 9 stimulant | 0.261 0.239 DBMET00611 | DBMET00611 | |
| 0.016 | 0.375 | 0.099 | CDK2/cyclin A inhibitor | 0.099 0.058 DBMET00271 | DBMET00271 | |
| 0.022 | 0.436 | 0.061 | Alpha 1b adrenoreceptor agonist | 0.061 0.019 DB00277 0.061 0.019 DBMET00271 | DBMET00271 | |
| 0.069 | 0.483 | 0.47 | Antibacterial | 0.47 0.05 DBMET00612 | DBMET00612 | |
| 0.014 | 0.453 | 0.091 | Glycogen synthase kinase-3 beta inhibitor | 0.091 0.09 DBMET00271 | DBMET00271 | |
| 0.008 | 0.483 | 0.133 | Check point kinase 1 inhibitor | 0.089 0.033 DBMET00223 0.12 0.02 DBMET00271 0.133 0.017 DBMET00560 | DBMET00560 | |
| 0.049 | 0.527 | 0.139 | Growth hormone agonist | 0.139 0.097 DBMET00560 | DBMET00560 | |
| 0.028 | 0.519 | 0.197 | Nav1.1 sodium channel blocker | 0.123 0.046 DBMET00222 0.197 0.019 DBMET00560 | DBMET00560 | |
| 0.018 | 0.517 | 0.438 | Uric acid excretion stimulant | 0.137 0.028 DBMET00271 0.383 0.004 DBMET00611 0.438 0.004 DBMET00560 | DBMET00560 | |
| 0.021 | 0.569 | 0.156 | Antimitotic | 0.156 0.115 DBMET00223 | DBMET00223 | |
| 0.005 | 0.573 | 0.12 | Protein kinase (CaMK, MLCK, PhK, SNF, KIN, NIM1, MAPKAP, POLO, CHK, ULK, RSK-2nd domain) inhibitor | 0.083 0.047 DBMET00223 0.116 0.029 DBMET00271 0.12 0.027 DBMET00560 | DBMET00560 | |
| 0.009 | 0.577 | 0.063 | MAP kinase kinase 10 inhibitor | 0.063 0.052 DBMET00612 | DBMET00612 | |
| 0.004 | 0.585 | 0.029 | Dopamine D1 agonist | 0.022 0.017 DBMET00222 0.029 0.009 DBMET00611 | DBMET00611 | |
| 0.022 | 0.664 | 0.152 | MAP3K9 inhibitor | 0.152 0.057 DBMET00271 | DBMET00271 | |
| 0.009 | 0.694 | 0.385 | Lipid peroxidase inhibitor | 0.385 0.01 DBMET00612 0.124 0.089 DBMET00560 | DBMET00612 | |
| 0.019 | 0.724 | 0.087 | Interleukin 5 antagonist | 0.087 0.06 DB01412 | DB01412 | |
| 0.01 | 0.841 | 0.057 | Sodium/calcium exchanger inhibitor | 0.057 0.022 DBMET00560 | DBMET00560 | |
| 0.005 | 0.859 | 0.13 | DNA intercalator | 0.13 0.052 DBMET00612 | DBMET00612 | |
| 0.036 | 0.924 | 0.251 | Interleukin 2 agonist | 0.251 0.117 DBMET00612 | DBMET00612 | |
| 0.006 | 0.928 | 0.064 | Aggrecanase 1 inhibitor | 0.064 0.008 DBMET00612 | DBMET00612 | |
| 0.003 | 0.952 | 0.016 | Antibiotic Tetracycline-like | 0.016 0.008 DBMET00612 | DBMET00612 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |